Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Nephrology | Family Medicine

Bladder Cancer Clinical Trials

A listing of Bladder Cancer medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 3 4 Last 

Alabama

University of Alabama Hematology Oncology Clinic at Medical West
Birmingham Alabama 35294

A clinical trial to evaluate treatments using OGX-427 and Docetaxel for patients with Bladder Cancer or Urothelial Carcinoma

University of Alabama Comprehensive Cancer Center
Birmingham Alabama 35294

A Phase 1/Phase 2 clinical study for patients with Non-muscle Invasive Bladder Cancer

Arizona

BCG Oncology
Phoenix Arizona 85032-2129

A clinical research study of CG0070 adenovirus vector and Control Arm: Quadruple Choice for the treatment of Transitional Cell Carcinoma, Bladder Cancer, Carcinoma in Situ or Carcinoma in Situ Concurrent With Papillary Tumors

Scottsdale Arizona 85258
Updated

A clinical research study of MPDL3280A for the treatment of Carcinoma, Transitional Cell , Bladder Cancer, Bladder Tumors, Urinary Bladder Neoplasms

Tucson Arizona 85710
Updated

A clinical research study of MPDL3280A for the treatment of Carcinoma, Transitional Cell , Bladder Cancer, Bladder Tumors, Urinary Bladder Neoplasms

The University of Arizona Cancer Center
Tucson Arizona 85724

Patients are needed to participate in a clinical research study of Cisplatin, Gemcitabine and ALT-801 to evaluate Transitional Cell Carcinoma of Bladder, Urethra Cancer, Ureter Cancer or Malignant Tumor of Renal Pelvis

California

City of Hope: Duarte
Duarte California 91010

A clinical trial to evaluate treatments using OGX-427 and Docetaxel for patients with Bladder Cancer or Urothelial Carcinoma

University of California, San Diego- Moores Cancer Center
La Jolla California 92093

A clinical research study of CG0070 adenovirus vector and Control Arm: Quadruple Choice for the treatment of Transitional Cell Carcinoma, Bladder Cancer, Carcinoma in Situ or Carcinoma in Situ Concurrent With Papillary Tumors

UCSD Moores Cancer Center
La Jolla California 92093

Patients are needed to participate in a clinical research study of Cisplatin, Gemcitabine and ALT-801 to evaluate Transitional Cell Carcinoma of Bladder, Urethra Cancer, Ureter Cancer or Malignant Tumor of Renal Pelvis

City of Hope: Antelope Valley
Lancaster California 93534

A clinical trial to evaluate treatments using OGX-427 and Docetaxel for patients with Bladder Cancer or Urothelial Carcinoma

University of California, Los Angeles
Los Angeles California 90024

A clinical research study of [124I] PSCA-Minibody PET/CT imaging of the whole body for the treatment of Prostate Cancer, Pancreatic Cancer or Bladder Cancer

View More »

UCLA Institute of Urological Oncology
Los Angeles California 90024

A clinical research study of CG0070 adenovirus vector and Control Arm: Quadruple Choice for the treatment of Transitional Cell Carcinoma, Bladder Cancer, Carcinoma in Situ or Carcinoma in Situ Concurrent With Papillary Tumors

Los Angeles California 90025
Updated

A clinical research study of MPDL3280A for the treatment of Carcinoma, Transitional Cell , Bladder Cancer, Bladder Tumors, Urinary Bladder Neoplasms

UCLA: Jonsson Comprehensive Cancer Center
Los Angeles California 90095

A clinical trial to evaluate treatments using OGX-427 and Docetaxel for patients with Bladder Cancer or Urothelial Carcinoma

VA Palo Alto Health Care System
Palo Alto California 94304

A clinical trial seeking patients for a research study for the treatment of Bladder Cancer

University of California, Davis- Cancer Center
Sacramento California 95817

A clinical research study of CG0070 adenovirus vector and Control Arm: Quadruple Choice for the treatment of Transitional Cell Carcinoma, Bladder Cancer, Carcinoma in Situ or Carcinoma in Situ Concurrent With Papillary Tumors

University of California Davis
Sacramento California 95817

A Phase 1/Phase 2 clinical study for patients with Non-muscle Invasive Bladder Cancer

San Marcos California 92069
Updated

A clinical research study of MPDL3280A for the treatment of Carcinoma, Transitional Cell , Bladder Cancer, Bladder Tumors, Urinary Bladder Neoplasms

Stanford California 94305-5820
Updated

A clinical research study of MPDL3280A for the treatment of Carcinoma, Transitional Cell , Bladder Cancer, Bladder Tumors, Urinary Bladder Neoplasms

Stanford University School of Medicine
Stanford California 94305

A clinical trial seeking patients for a research study of Pazopanib (GW786034) and Paclitaxel

Colorado

The Urology Center of Colorado
Denver Colorado 80211

A Phase 1/2a, placebo controlled, randomized study to evaluate the safety, immune response and clinical activity of HS-410 in patients with high risk superficial bladder cancer who have undergone Transurethral Resection of Bladder (TURBT) and received prior treatment with induction of Bacillus Calmette-Guerin (BCG).

View More »

Aurora Colorado 80045
Updated

A clinical research study of MPDL3280A for the treatment of Carcinoma, Transitional Cell , Bladder Cancer, Bladder Tumors, Urinary Bladder Neoplasms

Aurora Colorado 80012
Updated

A clinical research study of MPDL3280A for the treatment of Carcinoma, Transitional Cell , Bladder Cancer, Bladder Tumors, Urinary Bladder Neoplasms

University of Colorado Anschutz Medical Campus
Aurora Colorado 080045

Patients are needed to participate in a clinical research study of IMMU-132

Urology Center of Colorado
Denver Colorado 80211

A clinical trial to evaluate treatments using HS-410 and Placebo for patients with Bladder Cancer

Connecticut

Farmington Connecticut 06030
Updated

A clinical research study of MPDL3280A for the treatment of Carcinoma, Transitional Cell , Bladder Cancer, Bladder Tumors, Urinary Bladder Neoplasms

New Haven Connecticut 06520
Updated

A clinical research study of MPDL3280A for the treatment of Carcinoma, Transitional Cell , Bladder Cancer, Bladder Tumors, Urinary Bladder Neoplasms

Delaware

Helen F. Graham Cancer Center
Newark Delaware 19713

Patients are needed to participate in a clinical research study of IMMU-132

District of Columbia

Washington District of Columbia 20057
Updated

A clinical research study of MPDL3280A for the treatment of Carcinoma, Transitional Cell , Bladder Cancer, Bladder Tumors, Urinary Bladder Neoplasms

Florida

Jacksonville Florida 32224
Updated

A clinical research study of MPDL3280A for the treatment of Carcinoma, Transitional Cell , Bladder Cancer, Bladder Tumors, Urinary Bladder Neoplasms

M.D. Anderson Cancer Center Orlando
Orlando Florida 32806

Patients are needed to participate in a clinical research study of Cisplatin, Gemcitabine and ALT-801 to evaluate Transitional Cell Carcinoma of Bladder, Urethra Cancer, Ureter Cancer or Malignant Tumor of Renal Pelvis

MD Anderson Cancer Center Orlando
Orlando Florida 32806

Patients are needed to participate in a clinical research study of IMMU-132

Martin Health System
Stuart Florida 34994

A Phase 1/Phase 2 clinical study for patients with Non-muscle Invasive Bladder Cancer

Martin Health System
Stuart Florida 34994

Patients are needed to participate in a clinical research study of Cisplatin, Gemcitabine and ALT-801 to evaluate Transitional Cell Carcinoma of Bladder, Urethra Cancer, Ureter Cancer or Malignant Tumor of Renal Pelvis

View More »

H. Lee Moffitt Cancer Center and Research Institute
Tampa Florida 33612

A clinical trial seeking patients for a research study for the treatment of Bladder Cancer

H. Lee Moffitt Cancer Center and Research Institute
Tampa Florida 33612

Patients are needed to participate in a clinical research study of Cisplatin, Gemcitabine and ALT-801 to evaluate Transitional Cell Carcinoma of Bladder, Urethra Cancer, Ureter Cancer or Malignant Tumor of Renal Pelvis

Georgia

Emory University Department of Urology
Atlanta Georgia 30322

A clinical research study of Monopolar electrocautery loop in Transurethral resection of bladder tumors and PK Button Vaporization Electrode in transurethral resection of bladder tumors for the treatment of Bladder Cancer

The Emory Clinic
Atlanta Georgia 30322

Hexvix Cystoscopy for Detection of Bladder Cancer

Emory University
Atlanta Georgia 30322

Patients are needed to participate in a clinical research study of Cisplatin, Gemcitabine and ALT-801 to evaluate Transitional Cell Carcinoma of Bladder, Urethra Cancer, Ureter Cancer or Malignant Tumor of Renal Pelvis

Illinois

University of Chicago, Department of Surgery, Section of Urology
Chicago Illinois 60637

A clinical research study of CG0070 adenovirus vector and Control Arm: Quadruple Choice for the treatment of Transitional Cell Carcinoma, Bladder Cancer, Carcinoma in Situ or Carcinoma in Situ Concurrent With Papillary Tumors

Chicago Illinois 60637
Updated

A clinical research study of MPDL3280A for the treatment of Carcinoma, Transitional Cell , Bladder Cancer, Bladder Tumors, Urinary Bladder Neoplasms

Robert Lurie Comprehensive Cancer Center of Northwestern University
Chicago Illinois 60611

Patients are needed to participate in a clinical research study of Cisplatin, Gemcitabine and ALT-801 to evaluate Transitional Cell Carcinoma of Bladder, Urethra Cancer, Ureter Cancer or Malignant Tumor of Renal Pelvis

Harvey Illinois 60426
Updated

A clinical research study of MPDL3280A for the treatment of Carcinoma, Transitional Cell , Bladder Cancer, Bladder Tumors, Urinary Bladder Neoplasms

Indiana

First Urology, PSC
Jeffersonville Indiana 47130

A Phase 1/2, Placebo-Controlled, Randomized Study to Evaluate the Safety, Immune Response and Clinical Activity of HS-410 in Patients with High-Risk Non-Muscle Invasive Bladder Cancer.

View More »

IU Health Goshen Hospital
Goshen Indiana 46527

A clinical trial to evaluate treatments using OGX-427 and Docetaxel for patients with Bladder Cancer or Urothelial Carcinoma

IU Health Goshen Cancer Center
Goshen Indiana 46526

Patients are needed to participate in a clinical research study of IMMU-132

Indiana University Simon Cancer Center
Indianapolis Indiana 46202

A clinical trial to evaluate treatments using Amrubicin for patients with Bladder Cancer

Indiana University Melvin and Bren Simon Cancer Center
Indianapolis Indiana 46202

A clinical trial to evaluate treatments using Dovitinib for patients with Bladder Cancer

IU Health Central Indiana Cancer Centers
Indianapolis Indiana 46219

A clinical trial to evaluate treatments using OGX-427 and Docetaxel for patients with Bladder Cancer or Urothelial Carcinoma

Indiana University Melvin & Bren Simon Cancer Center
Indianapolis Indiana 46202

A clinical trial to evaluate treatments using OGX-427 and Docetaxel for patients with Bladder Cancer or Urothelial Carcinoma

First 1 2 3 4 Last